Search results
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 5 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Will there be a new Covid vaccine in the fall?
NBC News via Yahoo News· 4 days agoPfizer said Wednesday it can have updated Covid shots available “immediately upon approval” from the FDA; Moderna said it can have shots available to...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 4 days agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
First Human Death From Bird Flu Puts Vaccine Stocks On The Map - Moderna (NASDAQ:MRNA), CureVac...
Benzinga· 3 days agoVaccine stocks have been on the fly ever since a never-before-seen bird flu strain started infecting...
US FDA advisers to consider if new COVID shots should target JN.1 variant By Reuters
Investing.com· 7 days agoShares of Novavax (NASDAQ:NVAX) soared 11% in morning trade, after the documents were released. The...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via AOL· 7 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
Trending tickers: Berkshire Hathaway, Nvidia, Novavax and Adani Enterprises
Yahoo Finance UK· 6 days agoThe company continues to take big strides toward becoming the most valuable company on the planet....
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 5 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
Novavax Shares Jump on Planned Covid Vaccine Delivery
Market Watch· 4 days agoShares of Novavax climbed Thursday after the company said it would be able to deliver a regulator-recommended vaccine against a strain of Covid-19 by September. The stock ...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via Yahoo Finance· 3 days agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...